Spinal anesthesia for L5-S1 interlaminar endoscopic lumbar discectomy: a retrospective study.
Advantages
Complications
L5-S1 disc herniation
Percutaneous endoscopic interlaminar lumbar discectomy
Spinal anesthesia
Journal
BMC musculoskeletal disorders
ISSN: 1471-2474
Titre abrégé: BMC Musculoskelet Disord
Pays: England
ID NLM: 100968565
Informations de publication
Date de publication:
14 Oct 2023
14 Oct 2023
Historique:
received:
19
03
2023
accepted:
11
10
2023
medline:
23
10
2023
pubmed:
15
10
2023
entrez:
14
10
2023
Statut:
epublish
Résumé
This study aimed to report our experience with spinal anesthesia (SA) in patients undergoing L5-S1 interlaminar endoscopic lumbar discectomy (IELD) and clarify its advantages and disadvantages. One hundred twelve patients who underwent IELD for an L5-S1 disc herniation under SA were retrospectively analyzed. SA with 0.5% ropivacaine was administered using a 27-gauge fine needle. Intraoperatively, the volume and level of SA, surgical time, blood loss, and cardiopulmonary complications were documented. Postoperative data was collected included the number of patients who ambulated on the day of surgery, incidence of complications and were then statistically analyzed. Analgesia was complete throughout the entire operation in all patients and no other adjuvant intraoperative analgesic drugs were needed. Mean visual analog scale scores for intraoperative and early postoperative (24 h) pain were 0 and 2.43 ± 1.66. SA was administered at the L3-4 interspace in 34 patients (30.4%) and the L2-3 interspace in 78 (69.6%). Administration was successful with the first attempt in all patients. Mean operation time was 70.12 ± 6.52 min. Mean intraoperative blood loss volume was 20.71 ± 5.26 ml. Ninety-eight patients ambulated on the same day as surgery. Mean length of hospital stay was 24.36 ± 3.64 h. Dural injury without damaging the nerve root occurred in one patient. One patient experienced recurrent disc herniation. Intraoperative hypotension and respiratory distress occurred in five (4.5%) and three (2.7%) patients, respectively. Three patients (2.7%) received postoperative analgesia therapy and two (1.8%) experienced nausea. Two patients (1.8%) developed urinary retention. Spinal headache, cauda equina syndrome, and neurotoxicity did not occur. SA can achieve satisfactory pain control for patients undergoing IELD with a low incidence of adverse events. SA may be a useful alternative to local and general anesthesia for IELD surgery. Future randomized controlled trials are warranted to investigate.
Identifiants
pubmed: 37838709
doi: 10.1186/s12891-023-06956-z
pii: 10.1186/s12891-023-06956-z
pmc: PMC10576879
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
818Subventions
Organisme : Ningbo Yinzhou district agricultural and social development science and technology project fund
ID : 2018YZQ02029
Organisme : Ningbo Yinzhou district agricultural and social development science and technology project fund
ID : 2019AS0026
Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Pain Physician. 2020 Jan;23(1):49-56
pubmed: 32013278
Br J Surg. 1988 Apr;75(4):299-304
pubmed: 3282596
Rev Esp Anestesiol Reanim. 2002 Feb;49(2):71-5
pubmed: 12025250
Am J Surg. 2021 Apr;221(4):856-861
pubmed: 32933746
J Neurosurg Spine. 2016 Feb;24(2):275-280
pubmed: 26460752
Biomed Res Int. 2015;2015:453939
pubmed: 26064913
World J Clin Cases. 2021 Aug 16;9(23):6698-6704
pubmed: 34447816
Pain Res Manag. 2022 Feb 04;2022:2033580
pubmed: 35154550
J Clin Orthop Trauma. 2021 Jan 08;16:176-181
pubmed: 33717954
Eur J Anaesthesiol. 2022 Sep 1;39(9):733-734
pubmed: 35919025
Cah Anesthesiol. 1995;43(1):21-5
pubmed: 7671051
Medicine (Baltimore). 2018 May;97(19):e0693
pubmed: 29742719
Br J Anaesth. 2003 Nov;91(5):718-29
pubmed: 14570796
Pain Physician. 2019 Nov;22(6):E649-E654
pubmed: 31775418
Curr Top Med Chem. 2001 Aug;1(3):227-31
pubmed: 11895141
Rev Esp Anestesiol Reanim (Engl Ed). 2021 Oct;68(8):484-486
pubmed: 34521613
Anesth Analg. 2001 Jul;93(1):157-61
pubmed: 11429357
Surg Neurol Int. 2011;2:93
pubmed: 21748045
Anesthesiology. 2009 Feb;110(2):254-61
pubmed: 19194152
J Neurosurg Anesthesiol. 2017 Oct;29(4):415-425
pubmed: 27564561
Minim Invasive Neurosurg. 2006 Apr;49(2):80-7
pubmed: 16708336
Drug Des Devel Ther. 2022 Feb 09;16:315-323
pubmed: 35173415
Reg Anesth Pain Med. 2015 Sep-Oct;40(5):506-25
pubmed: 26263076
Medicine (Baltimore). 2017 Oct;96(43):e8427
pubmed: 29069043
Pain Physician. 2022 Nov;25(8):E1191-E1198
pubmed: 36375189
Global Spine J. 2023 Mar;13(2):575-587
pubmed: 35993298
J Pain Res. 2021 Jul 08;14:2039-2048
pubmed: 34267548
Br J Anaesth. 2003 Mar;90(3):309-13
pubmed: 12594142
J Res Med Sci. 2011 Apr;16(4):524-9
pubmed: 22091269
Clin Neurol Neurosurg. 2022 Nov;222:107454
pubmed: 36201900
Ann Palliat Med. 2020 May;9(3):1103-1108
pubmed: 32434370
World Neurosurg. 2019 Apr;124:e779-e782
pubmed: 30682512
J Orthop Surg Res. 2020 Sep 15;15(1):413
pubmed: 32933553
Pain Physician. 2018 Jul;21(4):E401-E408
pubmed: 30045606
Turk Neurosurg. 2014;24(3):380-4
pubmed: 24848178
Neurosurg Focus. 2021 Dec;51(6):E3
pubmed: 34852316
Surg Neurol. 1997 Sep;48(3):232-6
pubmed: 9290709
Br J Anaesth. 2002 Nov;89(5):702-6
pubmed: 12393766
PLoS One. 2021 Jul 30;16(7):e0247346
pubmed: 34329298
BMC Anesthesiol. 2022 May 18;22(1):152
pubmed: 35585483
Front Med (Lausanne). 2022 Sep 14;9:989341
pubmed: 36186818
Lancet. 2018 Mar 24;391(10126):1197-1204
pubmed: 29223694
World Neurosurg. 2022 Dec;168:324-332
pubmed: 36527212
J Sport Health Sci. 2022 Mar;11(2):212-223
pubmed: 34004389
Clin Spine Surg. 2023 Jul 1;36(6):227-236
pubmed: 35943881
Curr Opin Anaesthesiol. 2014 Oct;27(5):549-55
pubmed: 25051261
Ther Adv Neurol Disord. 2022 Aug 16;15:17562864221114356
pubmed: 35992893
Anesth Analg. 1959 Mar-Apr;38(2):118-24
pubmed: 13627523